Related Experiment Video
Updated: Jun 5, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
[Potassium channelopathies and Morvan's syndromes]
Georges Serratrice1, Jean-François Pellissier, Jacques Serra-Trice
1Membre de l'Académie nationale de médecine. georges.serratrice@dbmail.com
Morvan's syndrome is linked to potassium channelopathies, where faulty potassium regulation causes neuronal hyperexcitability. Understanding these channelopathies is key to treating neurological and cardiac conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Context:
- Morvan's disease and syndrome are increasingly recognized neurological disorders.
- Potassium channels play a critical role in neuronal function, particularly in repolarization and gating mechanisms.
- Dysregulation of potassium homeostasis can lead to neuronal hyperexcitability and associated channelopathies.
Purpose:
- To review the growing interest in Morvan's disease and its connection to potassium channelopathies.
- To elucidate the role of different potassium channel families (VGKC, Kir, K2p) in neurological and cardiac conditions.
- To highlight specific channelopathies, their genetic basis, and associated clinical manifestations.
Summary:
- Potassium channelopathies, disorders affecting potassium channels, are implicated in Morvan's syndrome and other neurological conditions.
- Voltage-gated potassium channels (VGKCs) are frequently involved, particularly Shaker-related channels linked to neuromyotonia and limbic encephalitis.
- Mutations in various potassium channel genes (KCNQ, KCNJ) cause diverse syndromes like long QT syndrome, benign familial neonatal seizures, DEND syndrome, and Andersen's syndrome.
Impact:
- Provides a comprehensive overview of potassium channelopathies and their clinical relevance.
- Enhances understanding of the molecular basis of neurological and cardiac channelopathies.
- Facilitates diagnosis and potential therapeutic strategies for patients with these conditions.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...

